Cargando…
Evaluation of the In Vitro Cytotoxic Activity of Ursolic Acid PLGA Nanoparticles against Pancreatic Ductal Adenocarcinoma Cell Lines
Among all the types of cancer, Pancreatic Ductal Adenocarcinoma remains one of the deadliest and hardest to fight and there is a critical unmet need for new drugs and therapies for its treatment. Naturally derived compounds, such as pentacyclic triterpenoids, have gathered attention because of their...
Autores principales: | Markowski, Adam, Migdał, Paweł, Zygmunt, Adrianna, Zaremba-Czogalla, Magdalena, Gubernator, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434451/ https://www.ncbi.nlm.nih.gov/pubmed/34501007 http://dx.doi.org/10.3390/ma14174917 |
Ejemplares similares
-
Design and Development of a New Type of Hybrid PLGA/Lipid Nanoparticle as an Ursolic Acid Delivery System against Pancreatic Ductal Adenocarcinoma Cells
por: Markowski, Adam, et al.
Publicado: (2022) -
Novel Liposomal Formulation of Baicalein for the Treatment of Pancreatic Ductal Adenocarcinoma: Design, Characterization, and Evaluation
por: Markowski, Adam, et al.
Publicado: (2023) -
Evaluation of the In Vitro Cytotoxic Activity of Caffeic Acid Derivatives and Liposomal Formulation against Pancreatic Cancer Cell Lines
por: Zaremba-Czogalla, Magdalena, et al.
Publicado: (2020) -
In Vitro Cytotoxicity of Oleanolic/Ursolic Acids-Loaded in PLGA Nanoparticles in Different Cell Lines
por: Silva, Amélia M., et al.
Publicado: (2019) -
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles
por: Wu, Shu-ta, et al.
Publicado: (2018)